×
  • Category
  • Type
  • Advanced

Janssen Ad26.COV2-S [recombinant], COVID-19 vaccine

KN3 Research for Equity

Mini-cPIE, aka COVID-19 Vaccination Intra-action Review (IAR)

Evaluation of COVID-19 vaccine effectiveness

Data for action: achieving high uptake of COVID-19 vaccines: Interim Guidance

Core data set for the Smart Vaccination Certificate

COMIRNATY® (Pfizer‒BioNTech) Training - Tozinameran COVID-19 mRNAVaccine (nucleoside modified)

COVID-19 Vaccine Explainer - Moderna COVID-19 vaccine (mRNA-1273)

COVID-19 vaccine checklist

Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

Interim recommendations for use of the AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ vaccine against COVID19 developed by Oxford University and AstraZeneca

Interim recommendations for the use of the Janssen Ad26.COV2.S (‎COVID-19)‎ vaccine: interim guidance, 17 March 2021

WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply

Fair allocation mechanism for COVID-19 vaccines through the COVAX Facility

COVID-19 Vaccine Explainer - AstraZeneca ChAdOx1-S/nCoV-19 [recombinant]

Interim guidance for developing a Smart Vaccination Certificate

Monitoring COVID-19 vaccination - Considerations for the collection and use of vaccination data

Background document on the AZD1222 vaccine against COVID-19 developed by Oxford University and AstraZeneca

MI4A Vaccine Purchase Data for Countries - 2020

Global Vaccine Market Report - 2020